Retatrutide is a synthetic peptide being investigated as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. Preclinical and ongoing clinical research has explored its potential role in metabolic function, glucose regulation, and energy homeostasis. As a triple receptor agonist, it is distinguished from single or dual agonists by its broader receptor activity profile, making it a subject of significant interest in current metabolic research. All research conducted with this compound should be performed in a controlled laboratory setting by qualified researchers only. For in-vitro research use only. Not for human consumption.<\/p>\n","protected":false},"excerpt":{"rendered":"
Retatrutide is a synthetic peptide being investigated as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. Preclinical and ongoing clinical research has explored its potential role in metabolic function, glucose regulation, and energy homeostasis. As a triple receptor agonist, it is distinguished from single or dual agonists by […]<\/p>\n","protected":false},"featured_media":109,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[18],"product_tag":[24,23,70,26,27,69,71],"class_list":["post-40","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic","product_tag-gip","product_tag-glp-1","product_tag-glucagon","product_tag-metabolic","product_tag-research-peptide","product_tag-retatrutide","product_tag-triple-agonist","first","instock","taxable","shipping-taxable","purchasable","product-type-variable"],"yoast_head":"\n